Antibody-drug conjugates: from efficacy testing to bioassay evaluation in modern drug development
{{output}}
Antibody-drug conjugates (ADCs) have emerged as one of the fastest-growing therapeutic modalities in oncology and are expanding in other disease areas as well, with 15 FDA-approved ADCs and over 250 drugs in different stages of development. The fact that they ... ...
